Correlation Engine 2.0
Clear Search sequence regions


  • amino acid (1)
  • anticodon (2)
  • binds (2)
  • cancer (1)
  • cell (1)
  • cell membrane (1)
  • facilitates (1)
  • KRS (7)
  • laminin receptor (6)
  • lysyl trna (2)
  • metastasis (2)
  • signals (1)
  • suppress (1)
  • tRNAs (1)
  • Sizes of these terms reflect their relevance to your search.

    Lysyl-tRNA synthetase (KRS) is an enzyme that conjugates lysine to its cognate tRNAs in the process of protein synthesis. In addition to its catalytic function, KRS binds to the 67-kDa laminin receptor (LR) on the cell membrane and facilitates cell migration and metastasis. Modulation of this interaction by small-molecule inhibitors can be exploited to suppress cancer metastasis. In this study, we present fragment-based methods for the identification of inhibitors and monitoring protein-protein interactions between KRS and LR. First, we identified the amino acid residues, located on the KRS anticodon-binding domain, which interact with the C-terminal extension of the LR. One-dimensional (1D) relaxation-edited nuclear magnetic resonance spectroscopy (NMR) and competition experiments were designed and optimized to screen the fragment library. For screening using two-dimensional (2D) NMR, we identified the indicative signals in the KRS anticodon-binding domain and selected inhibitors that bind to KRS and compete with LR at the KRS-LR binding interface. These methods may offer an efficient approach for the discovery of anti-metastatic drugs. Copyright © 2016. Published by Elsevier Inc.

    Citation

    Hye Young Cho, Sunghoon Kim, Young Ho Jeon. Fragment-based methods for the discovery of inhibitors modulating lysyl-tRNA synthetase and laminin receptor interaction. Methods (San Diego, Calif.). 2017 Jan 15;113:56-63


    PMID: 27789335

    View Full Text